Skip to main content
. 2013 Jun;51(6):1894–1898. doi: 10.1128/JCM.03290-12

Table 1.

Treatment effects measured with log CFU, TTP, and CTa

Measurement Group Baseline
Days 0–7
Days 0–14
n Value n Change in value P n Change in value P
Log CFU Group 1 14 5.51 (1.15) 11 −0.94 (1.76) 0.096 12 −0.97 (1.35) 0.018
Group 2 15 5.91 (0.77) 14 −0.32 (1.18) 0.429 13 −0.97 (0.72) 0.009
Group 3 14 5.42 (0.97) 13 +0.47 (1.41) 0.434 12 +0.17 (1.41) 0.994
Group 4 14 5.48 (0.91) 12 +0.19 (0.56) 0.367 12 +0.39 (0.76) 0.385
Group 5 13 6.34 (0.79) 12 −1.17 (0.82) 0.004 10 −1.84 (1.03) 0.0006
Group 6 13 5.67 (1.17) 13 +0.08 (0.47) 0.860 12 −0.28 (0.71) 0.384
Total 83 5.72 (1.00) 75 −0.26 (1.23) 0.2112 71 −0.55 (1.24) 0.0006
TTP Group 1 15 115.6 (39.4) 15 +83.7 (73.7) 0.0005 15 +91.5 (77.5) <0.0001
Group 2 15 100.0 (20.6) 15 +53.7 (40.6) 0.0002 15 +78.1 (54.5) <0.0001
Group 3 15 120.4 (56.0) 14 +10.6 (62.2) 0.607 12 +6.68 (36.7) 0.835
Group 4 15 125.7 (42.4) 15 −2.13 (23.2) 0.897 15 −11.3 (24.9) 0.423
Group 5 15 124.3 (77.4) 14 +70.5 (50.9) 0.073 13 +151.1 (125.1) 0.004
Group 6 15 110.1 (24.5) 15 −2.52 (21.9) 0.770 14 +13.2 (41.0) 0.365
Total 90 116.0 (47.6) 88 +35.5 (59.3) 0.0002 84 +54.8 (86.8) <0.0001
CT Group 1 14 19.1 (4.57) 11 +2.33 (2.80) 0.331 14 +3.87 (5.75) 0.030
Group 2 14 18.9 (3.81) 12 +1.06 (3.18) 0.476 15 +1.27 (3.32) 0.311
Group 3 14 19.6 (3.54) 10 −0.92 (2.71) 0.181 12 +0.61 (3.86) 0.478
Group 4 14 20.1 (4.45) 14 +0.77 (2.18) 0.628 14 +1.29 (3.60) 0.524
Group 5 13 17.9 (3.27) 12 +0.91 (3.72) 0.425 11 +3.56 (2.63) 0.021
Group 6 14 20.0 (3.34) 14 −0.87 (3.05) 0.277 15 +1.85 (5.58) 0.350
Total 83 19.3 (3.88) 73 +0.55 (3.07) 0.6030 81 +2.06 (4.37) 0.0020
a

Baseline values are means ± standard deviations. All P values were calculated using unpaired Student's t test. n, number of patients with measurements.